TAVR valve for severe aortic regurgitation in high-risk patients
Part of Heart & circulation clinical trials.
This trial tests whether a new valve replacement procedure (TAVR) is safe and effective for people with severe aortic regurgitation, a leaky heart valve. It is designed for patients who are not good candidates for open-heart surgery because of other health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have severe aortic regurgitation (a leaky heart valve) with no significant narrowing or calcium buildup
- You have symptoms like shortness of breath or fatigue (New York Heart Association Class II or higher)
- Your doctor and heart team agree that traditional surgery is high risk for you
- You are suitable for the transfemoral approach (through the leg artery) for the valve replacement
- You are willing to attend follow-up visits after the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a less invasive heart valve replacement (TAVR) for people with a leaky aortic valve (aortic regurgitation). It uses ultrasound guidance to place the new valve, which may offer a treatment option for those who cannot have open-heart surgery.
This trial is testing a less invasive procedure (TAVR) to fix a leaky aortic valve without open-heart surgery. It's for people with severe aortic regurgitation who are either having symptoms or showing signs of heart strain, and who are not good candidates for traditional surgery.
This trial tests the VitaFlow Liberty device, a catheter-based treatment for people with severe aortic regurgitation (a leaky heart valve). If you have symptoms or your heart is starting to weaken, this procedure might help avoid open-heart surgery.
This trial compares a new less-invasive valve replacement (Trilogy TAVR) with standard open-heart surgery for people with significant aortic regurgitation. It aims to see which treatment works better for patients who are eligible for both procedures.
This trial compares a new catheter-based valve (J-Valve) with open-heart surgery for people with severe aortic regurgitation, a condition where the aortic valve doesn't close tightly. It aims to see which treatment is safer and more effective.
This trial tests a procedure called TAVR to replace the aortic valve in people with severe aortic regurgitation (a leaky valve). It may help you if you have this condition and prefer a less invasive option than open-heart surgery.
Hear when a new Aortic Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.